Sep 2026· Annals of Surgical Oncology· 0 citations· 21 references
Medicine
TL;DR
Achieving salvage R0 resection provides a significant survival benefit comparable to repeat hepatectomy outcomes, and aggressive local intervention aimed at R0 resection should be considered a key therapeutic strategy.
BACKGROUND AND OBJECTIVES
Recurrence risk after hepatectomy for colorectal liver metastases (CRLMs) changes during follow-up, but whether baseline tumor burden remains prognostically relevant with increasing recurrence-free time is unclear. We evaluated the time-dependent prognostic relevance of liver metastasis number...
Taiki Mori, N. Sakai, T. Takayashiki et al.· Journal of Surgical Oncology· 0 citations
BACKGROUND
Conventional survival analyses cannot fully account for recurrence as an intermediate event that dynamically influences subsequent mortality. Multistate models (MSMs) enable explicit modeling of transitions between clinically relevant disease states; however, their application among patients undergoing resec...
Andrea Baldo, Miho Akabane, C. Charalampous et al.· Annals of Surgical Oncology· 0 citations
Therapeutic re-resection at first recurrence was associated with improved post-recurrence survival, which remained significant after multivariable adjustment or propensity score matching, which remained significant after multivariable adjustment or propensity score matching.
David A. Giles, Jing Wang, Markus Anzaldua-Campos et al.· Neuro-Oncology Advances· 0 citations
BACKGROUND
Recurrence after curative resection of colorectal liver metastases (CRLM) is heterogeneous. Early recurrence not always implies futile surgery. This study distinguishes predictors of early recurrence versus futile surgery and examines recurrence patterns.
METHODS
This study analyzed the prospective LiMeT c...
R. Marino, Buonanno Silvia, Catena Marco et al.· HPB· 0 citations
Background Recurrence remains common after initial transurethral resection of bladder tumor (TURBT) for non–muscle-invasive bladder cancer (NMIBC). This study aimed to identify routinely available clinicopathological, treatment-related, and inflammatory factors associated with recurrence and to characterize recurrence-...
F. Yuan, Xiong Li, Jing Zhang et al.· Frontiers in Oncology· 0 citations
INTRODUCTION
Parenchymal-sparing one-stage hepatectomy (POSH) has expanded surgical eligibility for patients with high-burden (≥10) colorectal liver metastases (CLM). Early recurrence (ER), defined as recurrence within 6 months, remains a challenge, and its prognostic significance and preoperative predictability in thi...
F. Milana, F. Procopio, G. Rodda et al.· European Journal of Surgical...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.